PE/FireTM 744 anti-mouse CD127 (IL-7Ralpha) [S18006K]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0454694
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $476.00
About this award
The University of Virginia awarded contract A207_PO-0454694 to BioLegend Inc. on July 3, 2026, for the delivery of laboratory reagents and supplies. The contract encompasses the procurement of PE/Fire 744 anti-mouse CD127 (IL-7R alpha) monoclonal antibodies, with a total cumulative contract value of $476. The deliverable consists of two units at a unit price of $238 each, with delivery directed to Kelsey Voss at the University of Virginia in Virginia.
BioLegend Inc. serves as the prime contractor for this award, which falls under the Commonwealth of Virginia. The contract represents a direct purchase transaction for immunological research reagents commonly utilized in flow cytometry and cellular immunology applications. The relatively modest contract value and single line item structure indicate this constitutes a straightforward procurement of specialized scientific materials required for research operations at the University of Virginia.
Line items
| Item | Total |
|---|---|
| PE/FireTM 744 anti-mouse CD127 (IL-7Ralpha) [S18006K] | $476.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0454694?
Contract A207_PO-0454694 was awarded to BIOLEGEND INC. by University of Virginia on July 3, 2026.
How much is contract A207_PO-0454694 worth?
Its cumulative value is $476.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award